Hong Kong · Delayed Price · Currency is HKD Biosysen Statistics
Total Valuation
Biosysen has a market cap or net worth of HKD 304.23 million. The enterprise value is 366.58 million.
| Market Cap | 304.23M |
| Enterprise Value | 366.58M |
Important Dates
The last earnings date was Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biosysen has 1.79 billion shares outstanding. The number of shares has increased by 54.36% in one year.
| Current Share Class | 1.79B |
| Shares Outstanding | 1.79B |
| Shares Change (YoY) | +54.36% |
| Shares Change (QoQ) | +7.04% |
| Owned by Insiders (%) | 11.26% |
| Owned by Institutions (%) | n/a |
| Float | 1.24B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.97 |
| PB Ratio | -5.76 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.14
| Current Ratio | 0.14 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.86 |
| Interest Coverage | -7.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -27.23% |
| Return on Invested Capital (ROIC) | -37.42% |
| Return on Capital Employed (ROCE) | 230.55% |
| Weighted Average Cost of Capital (WACC) | 3.60% |
| Revenue Per Employee | 760,388 |
| Profits Per Employee | -132,821 |
| Employee Count | 67 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 129.89 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.00% in the last 52 weeks. The beta is -0.10, so Biosysen's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | +36.00% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 59.33 |
| Average Volume (20 Days) | 444,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biosysen had revenue of HKD 50.95 million and -8.90 million in losses. Loss per share was -0.01.
| Revenue | 50.95M |
| Gross Profit | 8.73M |
| Operating Income | -33.77M |
| Pretax Income | 22.12M |
| Net Income | -8.90M |
| EBITDA | -25.92M |
| EBIT | -33.77M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.09 million in cash and 101.91 million in debt, with a net cash position of -100.82 million or -0.06 per share.
| Cash & Cash Equivalents | 1.09M |
| Total Debt | 101.91M |
| Net Cash | -100.82M |
| Net Cash Per Share | -0.06 |
| Equity (Book Value) | -52.86M |
| Book Value Per Share | -0.01 |
| Working Capital | -73.82M |
Cash Flow
In the last 12 months, operating cash flow was -4.72 million and capital expenditures -6.78 million, giving a free cash flow of -11.50 million.
| Operating Cash Flow | -4.72M |
| Capital Expenditures | -6.78M |
| Depreciation & Amortization | 7.85M |
| Net Borrowing | 10.54M |
| Free Cash Flow | -11.50M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 17.14%, with operating and profit margins of -66.29% and -17.47%.
| Gross Margin | 17.14% |
| Operating Margin | -66.29% |
| Pretax Margin | 43.42% |
| Profit Margin | -17.47% |
| EBITDA Margin | -50.88% |
| EBIT Margin | -66.29% |
| FCF Margin | n/a |
Dividends & Yields
Biosysen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.36% |
| Shareholder Yield | -54.36% |
| Earnings Yield | -2.93% |
| FCF Yield | -3.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biosysen has an Altman Z-Score of -8.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.27 |
| Piotroski F-Score | 2 |